Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, Peter C, Boss, David S, Yap, Timothy A, Tutt, Andrew, Wu, Peijun, Mergui-Roelvink, Marja, Mortimer, Peter, Swaisland, Helen, Lau, Alan, O'Connor, Mark J, Ashworth, Alan, Carmichael, James, Kaye, Stan B, Schellens, Jan H.M, de Bono, Johann S
Published in The New England journal of medicine (09.07.2009)
Published in The New England journal of medicine (09.07.2009)
Get full text
Journal Article
Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers
Nemati Shafaee, Maryam, Goutsouliak, Kristina, Lin, Heather, Bevers, Therese B., Gutierrez-Barrera, Angelica, Bondy, Melissa, Arun, Banu
Published in Breast cancer research and treatment (01.11.2022)
Published in Breast cancer research and treatment (01.11.2022)
Get full text
Journal Article
Surgical management of BRCA-mutation carriers: A single institution experience
Gentile, Damiano, Losurdo, Agnese, Sagona, Andrea, Zuradelli, Monica, Gatzemeier, Wolfgang, Barbieri, Erika, Testori, Alberto, Errico, Valentina, Bianchi, Paolo, Biondi, Ersilia, Torrisi, Rosalba, Santoro, Armando, Tinterri, Corrado
Published in European journal of surgical oncology (01.08.2022)
Published in European journal of surgical oncology (01.08.2022)
Get full text
Journal Article
Abstract 4433: Effectiveness of USP1 inhibitor (VRTX531) in gynecological cancers with diverse BRCA mutation status
Surampudi, Uday Kumar, Bhavar, Prashant Kashinath, Sarma, Partha Pratim, Rahangdale, Rishi, Kshirsagar, Anuj Ramesh, Mandhare, Appaji Baburao
Published in Cancer research (Chicago, Ill.) (21.04.2025)
Published in Cancer research (Chicago, Ill.) (21.04.2025)
Get full text
Journal Article
BRCA mutation screening and patterns among high-risk Lebanese subjects
Farra, Chantal, Dagher, Christelle, Badra, Rebecca, Hammoud, Miza Salim, Alameddine, Raafat, Awwad, Johnny, Seoud, Muhieddine, Abbas, Jaber, Boulos, Fouad, El Saghir, Nagi, Mukherji, Deborah
Published in Hereditary cancer in clinical practice (18.01.2019)
Published in Hereditary cancer in clinical practice (18.01.2019)
Get full text
Journal Article
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation
Finch, A., Metcalfe, K.A., Chiang, J.K., Elit, L., McLaughlin, J., Springate, C., Demsky, R., Murphy, J., Rosen, B., Narod, S.A.
Published in Gynecologic oncology (01.04.2011)
Published in Gynecologic oncology (01.04.2011)
Get full text
Journal Article
Pilot study of rapid MR pancreas screening for patients with BRCA mutation
Corrias, Giuseppe, Raeside, Mitchell C., Agostini, Andrea, Huicochea-Castellanos, Sandra, Aramburu-Nunez, David, Paudyal, Ramesh, Shukla-Dave, Amita, Smelianskaia, Olga, Capanu, Marinela, Zheng, Junting, Fung, Maggie, Kelsen, David P., Mangino, Debra A., Robson, Mark E., Goldfrank, Deborah J., Carter, Jean, Allen, Peter J., Conti, Bettina, Monti, Serena, Do, Richard K. G., Mannelli, Lorenzo
Published in European radiology (01.08.2019)
Published in European radiology (01.08.2019)
Get full text
Journal Article
2022-RA-1020-ESGO Family history in BRCA mutation carriers affected by breast and ovarian cancer and its role in identifying subjects at high risk
Negri, Serena, de Ponti, Elena, Sina, Federica Paola, Sala, Elena, Dell’Oro, Cristina, Roversi, Gaia, Lazzarin, Sara, Marchette, Martina Delle, Inzoli, Alessandra, Toso, Claudia, Fumagalli, Simona, Campanella, Ornella, Kotsopoulos, Joanne, Fruscio, Robert
Published in International journal of gynecological cancer (01.10.2022)
Published in International journal of gynecological cancer (01.10.2022)
Get full text
Journal Article
Germline BRCA mutation does not prevent response to taxane‐based therapy for the treatment of castration‐resistant prostate cancer
Gallagher, David J., Cronin, Angel M., Milowsky, Matthew I., Morris, Michael J., Bhatia, Jasmine, Scardino, Peter T., Eastham, James A., Offit, Kenneth, Robson, Mark E.
Published in BJU international (01.03.2012)
Published in BJU international (01.03.2012)
Get full text
Journal Article
BRCA mutation carriers suffering from ovarian cancer as a model for treatment decision in higher lines - Place for platinum reinduction
Zikan, Michal, Vecerova, Livia, Dubova, Olga, Sehnal, Borek, Soukupova, Jana
Published in Journal of cancer research and therapeutics (01.04.2023)
Published in Journal of cancer research and therapeutics (01.04.2023)
Get full text
Journal Article
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers
Tommasi, Chiara, Pellegrino, Benedetta, Boggiani, Daniela, Sikokis, Angelica, Michiara, Maria, Uliana, Vera, Bortesi, Beatrice, Bonatti, Francesco, Mozzoni, Paola, Pinelli, Silvana, Squadrilli, Anna, Viani, Maria Vittoria, Cassi, Diana, Maglietta, Giuseppe, Meleti, Marco, Musolino, Antonino
Published in Frontiers in oncology (06.09.2021)
Published in Frontiers in oncology (06.09.2021)
Get full text
Journal Article
Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?
Grandi, Giovanni, Perrone, Anna Myriam, Perrone, Antonino, Mandato, Vincenzo Dario, Comerci, Giuseppe, Sammarini, Margaret, Merisio, Carla, Amadori, Andrea, Stefanetti, Marco, Martinello, Ruby, Facchinetti, Fabio, De Iaco, Pierandrea, Aguzzoli, Lorenzo, Arcangeli, Valentina, Berretta, Roberto, Cortesi, Laura, De Domenico, Roberta, Nuzzo, Maria De, Friso, Stefano, Greco, Pantaleo, Rosati, Federica, Scutiero, Gennaro, Toss, Angela
Published in Maturitas (01.01.2021)
Published in Maturitas (01.01.2021)
Get full text
Journal Article
Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation
Lee, Hee Eun, Arshad, Muhammad, Brahmbhatt, Rushin D., Hoskin, Tanya L., Winham, Stacey J., Frost, Marlene H., Radisky, Derek C., Denison, Lori A., Degnim, Amy C., Visscher, Daniel W.
Published in Modern pathology (01.09.2019)
Published in Modern pathology (01.09.2019)
Get full text
Journal Article
Harnessing olaparib, palbociclib, and endocrine therapy: A phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA mutation-associated, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (HOPE)
Aaron, Megan, White, Lia, D'Andrea, Kurt, Narayan, Vivek, Knollman, Hayley Michelle, Bradbury, Angela R., Tung, Nadine M., Robson, Mark E., Nathanson, Katherine, Domchek, Susan M., Shah, Payal Deepak
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group
Bu, Hualei, Chen, Jingying, Li, Qingshui, Hou, Jianqing, Wei, Yuan, Yang, Xiaohang, Ma, Yana, He, Hongsheng, Zhang, Youzhong, Kong, Beihua
Published in The journal of obstetrics and gynaecology research (01.11.2019)
Published in The journal of obstetrics and gynaecology research (01.11.2019)
Get full text
Journal Article
Abstract OT2-01-13: A phase 3, open-label, randomized, 2-arm international study of the oral dual PARP inhibitor talazoparib in germline BRCA mutation subjects with locally advanced and/or metastatic breast cancer (EMBRACA)
Litton, J, Ettl, J, Hurvitz, SA, Mina, LA, Rugo, HS, Lee, K-H, Yerushalmi, R, Woodward, N, Goncalves, A, Moreno, F, Roche, H, Im, Y-H, Martin, M, Bhattacharya, S, Peterson, A, Hannah, A, Eiermann, W, Blum, J
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract OT1-03-16: EMBRACA: A phase 3, open-label, randomized, parallel, 2-arm international study of the oral PARP inhibitor talazoparib (BMN 673) versus physician's choice in BRCA mutation subjects with locally advanced and/or metastatic breast cancer
Litton, JK, Blum, JL, Im, Y-H, Martin, M, Mina, L, Roché, H, Visco, F, Yang, X, Lokker, NA, Lounsbury, DL, Eiermann, W
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract OT1-03-17: ABRAZO: An international phase 2 (2-stage, 2-cohort) study of the oral PARP inhibitor talazoparib (BMN 673) in BRCA mutation subjects with locally advanced and/or metastatic breast cancer
Turner, NC, Balmaña, J, Fasching, PA, Hurvitz, SA, Rugo, HS, Telli, ML, Visco, F, Wardley, AM, Yang, X, Lokker, NA, Lounsbury, DL, Robson, ME
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
P1.01A phase 3 study of the oral PARP inhibitor talazoparib (BMN 673) in BRCA mutation subjects with advanced breast cancer (EMBRACA)
Roche, H, Blum, J, Eiermann, W, Im, Y-H, Martin, M, Mina, L, Rugo, H, Visco, F, Zhang, C, Lokker, N, Lounsbury, D, Litton, J
Published in Annals of oncology (01.03.2015)
Published in Annals of oncology (01.03.2015)
Get full text
Journal Article